Cargando…
Silencing of lysyl oxidase-like 2 inhibits the migration, invasion and epithelial-to-mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway
The aim of the present study was to investigate the effects of lysyl oxidase-like 2 (LOXL2) on the invasion, migration and epithelial-to-mesenchymal transition (EMT) of renal cell carcinoma (RCC) cells through the steroid receptor coactivator (Src)/focal adhesion kinase (FAK) signaling pathway. RCC...
Autores principales: | Hong, Xi, Yu, Jian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438419/ https://www.ncbi.nlm.nih.gov/pubmed/30816490 http://dx.doi.org/10.3892/ijo.2019.4726 |
Ejemplares similares
-
Lysyl Oxidase at the Crossroads of Mesenchymal Stem Cells and Epithelial-Mesenchymal Transition
por: Thomas, Clémence, et al.
Publicado: (2013) -
Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3
por: Lee, Jaewon J., et al.
Publicado: (2018) -
Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
por: Umezaki, Naoki, et al.
Publicado: (2019) -
FAK competes for Src to promote migration against invasion in melanoma cells
por: Kolli-Bouhafs, K, et al.
Publicado: (2014) -
Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK/p-paxillin/YAP signaling
por: Liu, Xue, et al.
Publicado: (2023)